T
Tikun Olam Cannbit Pharmaceuticals Ltd
TASE:TKUN
Tikun Olam Cannbit Pharmaceuticals Ltd
TASE:TKUN
Price:
1 964
ILS
Market Closed
Market Cap:
₪16.7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Popular Picks
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Tikun Olam Cannbit Pharmaceuticals Ltd
Research & Development
Last
Value
3 Years
3Y
CAGR
5 Years
5Y
CAGR
10 Years
10Y
CAGR
|
See Also
Tikun Olam Cannbit Pharmaceuticals Ltd
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
T
|
Tikun Olam Cannbit Pharmaceuticals Ltd
TASE:TKUN
|
Research & Development
-₪145k
|
CAGR 3-Years
71%
|
CAGR 5-Years
35%
|
CAGR 10-Years
N/A
|
|
|
Teva Pharmaceutical Industries Ltd
TASE:TEVA
|
Research & Development
-$1B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
0%
|
CAGR 10-Years
4%
|
|
|
Sol Gel Technologies Ltd
NASDAQ:SLGL
|
Research & Development
-$24.4m
|
CAGR 3-Years
-22%
|
CAGR 5-Years
4%
|
CAGR 10-Years
N/A
|
|
|
PolyPid Ltd
NASDAQ:PYPD
|
Research & Development
-$23.8m
|
CAGR 3-Years
5%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
N/A
|
|
|
Mediwound Ltd
NASDAQ:MDWD
|
Research & Development
-$13.5m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-8%
|
|
|
R
|
Rekah Pharmaceutical Industry Ltd
TASE:REKA
|
Research & Development
-₪4.4m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
-5%
|
|
No Stocks Found
Tikun Olam Cannbit Pharmaceuticals Ltd
Glance View
Tikun Olam-Cannbit Pharmaceuticals Ltd. engages in the cultivation and marketing of medical cannabis. The firm engages in growing and cultivating medical cannabis products.
TKUN
Intrinsic Value
3 181.18
ILS
Undervaluation 38%
T
See Also
What is Tikun Olam Cannbit Pharmaceuticals Ltd's Research & Development?
Research & Development
-145k
ILS
-145k
ILS
Based on the financial report for Jun 30, 2025, Tikun Olam Cannbit Pharmaceuticals Ltd's Research & Development amounts to -145k ILS.
What is Tikun Olam Cannbit Pharmaceuticals Ltd's Research & Development growth rate?
Research & Development CAGR 5Y
35%
35%
Over the last year, the Research & Development growth was 90%. The average annual Research & Development growth rates for Tikun Olam Cannbit Pharmaceuticals Ltd have been 71% over the past three years , 35% over the past five years .
